A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma

Glioma represents the most common primary cancer of the central nervous system in adults. Glycosylation is a prevalent post-translational modification that occurs in eukaryotic cells, leading to a wide array of modifications on proteins. We obtained the clinical information, bulk RNA-seq data, and s...

Full description

Bibliographic Details
Main Authors: Yanbo Yang, Haiying Teng, Yulian Zhang, Fei Wang, Liyan Tang, Chuanpeng Zhang, Ziyi Hu, Yuxuan Chen, Yi Ge, Zhong Wang, Yanbing Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1259051/full
_version_ 1797354417969692672
author Yanbo Yang
Haiying Teng
Haiying Teng
Yulian Zhang
Fei Wang
Fei Wang
Liyan Tang
Chuanpeng Zhang
Chuanpeng Zhang
Ziyi Hu
Ziyi Hu
Yuxuan Chen
Yuxuan Chen
Yi Ge
Zhong Wang
Yanbing Yu
author_facet Yanbo Yang
Haiying Teng
Haiying Teng
Yulian Zhang
Fei Wang
Fei Wang
Liyan Tang
Chuanpeng Zhang
Chuanpeng Zhang
Ziyi Hu
Ziyi Hu
Yuxuan Chen
Yuxuan Chen
Yi Ge
Zhong Wang
Yanbing Yu
author_sort Yanbo Yang
collection DOAJ
description Glioma represents the most common primary cancer of the central nervous system in adults. Glycosylation is a prevalent post-translational modification that occurs in eukaryotic cells, leading to a wide array of modifications on proteins. We obtained the clinical information, bulk RNA-seq data, and single-cell RNA sequencing (scRNA-seq) from The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), Gene Expression Omnibus (GEO), and Repository of Molecular Brain Neoplasia Data (Rembrandt) databases. RNA sequencing data for normal brain tissues were accessed from the Genotype-Tissue Expression (GTEx) database. Then, the glycosylation genes that were differentially expressed were identified and further subjected to variable selection using a least absolute shrinkage and selection operator (LASSO)-regularized Cox model. We further conducted enrichment analysis, qPCR, nomogram, and single-cell transcriptome to detect the glycosylation signature. Drug sensitivity analysis was also conducted. A five-gene glycosylation signature (CHPF2, PYGL, GALNT13, EXT2, and COLGALT2) classified patients into low- or high-risk groups. Survival analysis, qPCR, ROC curves, and stratified analysis revealed worse outcomes in the high-risk group. Furthermore, GSEA and immune infiltration analysis indicated that the glycosylation signature has the potential to predict the immune response in glioma. In addition, four drugs (crizotinib, lapatinib, nilotinib, and topotecan) showed different responses between the two risk groups. Glioma cells had been classified into seven lines based on single-cell expression profiles. The five-gene glycosylation signature can accurately predict the prognosis of glioma and may offer additional guidance for immunotherapy.
first_indexed 2024-03-08T13:50:09Z
format Article
id doaj.art-44d481ab91d34c4aa6b7612fe2ad69b1
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-08T13:50:09Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-44d481ab91d34c4aa6b7612fe2ad69b12024-01-16T04:35:29ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-01-011410.3389/fphar.2023.12590511259051A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in gliomaYanbo Yang0Haiying Teng1Haiying Teng2Yulian Zhang3Fei Wang4Fei Wang5Liyan Tang6Chuanpeng Zhang7Chuanpeng Zhang8Ziyi Hu9Ziyi Hu10Yuxuan Chen11Yuxuan Chen12Yi Ge13Zhong Wang14Yanbing Yu15China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaSuzhou Medical College of Soochow University, Suzhou, Jiangsu, ChinaDepartment of Neurosurgery, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaSuzhou Medical College of Soochow University, Suzhou, Jiangsu, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaDepartment of Neurosurgery, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, ChinaDepartment of Neurosurgery, China-Japan Friendship Hospital, Beijing, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaSuzhou Medical College of Soochow University, Suzhou, Jiangsu, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaSuzhou Medical College of Soochow University, Suzhou, Jiangsu, ChinaThe Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaDepartment of Neurosurgery and Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, ChinaChina-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaGlioma represents the most common primary cancer of the central nervous system in adults. Glycosylation is a prevalent post-translational modification that occurs in eukaryotic cells, leading to a wide array of modifications on proteins. We obtained the clinical information, bulk RNA-seq data, and single-cell RNA sequencing (scRNA-seq) from The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), Gene Expression Omnibus (GEO), and Repository of Molecular Brain Neoplasia Data (Rembrandt) databases. RNA sequencing data for normal brain tissues were accessed from the Genotype-Tissue Expression (GTEx) database. Then, the glycosylation genes that were differentially expressed were identified and further subjected to variable selection using a least absolute shrinkage and selection operator (LASSO)-regularized Cox model. We further conducted enrichment analysis, qPCR, nomogram, and single-cell transcriptome to detect the glycosylation signature. Drug sensitivity analysis was also conducted. A five-gene glycosylation signature (CHPF2, PYGL, GALNT13, EXT2, and COLGALT2) classified patients into low- or high-risk groups. Survival analysis, qPCR, ROC curves, and stratified analysis revealed worse outcomes in the high-risk group. Furthermore, GSEA and immune infiltration analysis indicated that the glycosylation signature has the potential to predict the immune response in glioma. In addition, four drugs (crizotinib, lapatinib, nilotinib, and topotecan) showed different responses between the two risk groups. Glioma cells had been classified into seven lines based on single-cell expression profiles. The five-gene glycosylation signature can accurately predict the prognosis of glioma and may offer additional guidance for immunotherapy.https://www.frontiersin.org/articles/10.3389/fphar.2023.1259051/fullglycosylationgliomatumor microenvironmentprognosisimmunitydrug sensitivity
spellingShingle Yanbo Yang
Haiying Teng
Haiying Teng
Yulian Zhang
Fei Wang
Fei Wang
Liyan Tang
Chuanpeng Zhang
Chuanpeng Zhang
Ziyi Hu
Ziyi Hu
Yuxuan Chen
Yuxuan Chen
Yi Ge
Zhong Wang
Yanbing Yu
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
Frontiers in Pharmacology
glycosylation
glioma
tumor microenvironment
prognosis
immunity
drug sensitivity
title A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
title_full A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
title_fullStr A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
title_full_unstemmed A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
title_short A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
title_sort glycosylation related gene signature predicts prognosis immune microenvironment infiltration and drug sensitivity in glioma
topic glycosylation
glioma
tumor microenvironment
prognosis
immunity
drug sensitivity
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1259051/full
work_keys_str_mv AT yanboyang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT haiyingteng aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT haiyingteng aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yulianzhang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT feiwang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT feiwang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT liyantang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT chuanpengzhang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT chuanpengzhang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT ziyihu aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT ziyihu aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yuxuanchen aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yuxuanchen aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yige aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT zhongwang aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yanbingyu aglycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yanboyang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT haiyingteng glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT haiyingteng glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yulianzhang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT feiwang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT feiwang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT liyantang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT chuanpengzhang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT chuanpengzhang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT ziyihu glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT ziyihu glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yuxuanchen glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yuxuanchen glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yige glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT zhongwang glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma
AT yanbingyu glycosylationrelatedgenesignaturepredictsprognosisimmunemicroenvironmentinfiltrationanddrugsensitivityinglioma